AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance

Molecular Cell

Volumn 66, Issue 6, 2017, Pages 789-800

  Garcia, Daniel ^a   Shaw, Reuben J ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

AMPK; energy restoration; metabolic adaptation; therapeutic activation; trimeric complex

Indexed keywords

ADENYLATE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; NUCLEOTIDE; ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TARGET OF RAPAMYCIN KINASE;

AUTOPHAGY; CELL ENERGY; CELLULAR DISTRIBUTION; CRYSTAL STRUCTURE; ENERGY BALANCE; ENZYME ACTIVATION; GLUCOSE METABOLISM; LIPID METABOLISM; METABOLIC BALANCE; METABOLIC REGULATION; METABOLIC STRESS; MITOPHAGY; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; CHEMISTRY; DRUG EFFECTS; ENERGY METABOLISM; ENZYMOLOGY; HUMAN; METABOLIC DISEASES; METABOLISM; MITOCHONDRION; MOLECULAR MODEL; PATHOLOGY; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOPHAGY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVATORS; HUMANS; METABOLIC DISEASES; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEOLYSIS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TOR SERINE-THREONINE KINASES;

EID: 85020822242     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2017.05.032     Document Type: Review

References (107)

1. Ahmadian, M., Abbott, M.J., Tang, T., Hudak, C.S.S., Kim, Y., Bruss, M., Hellerstein, M.K., Lee, H.-Y., Samuel, V.T., Shulman, G.I., et al. Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab. 13 (2011), 739–748.
2. Asby, D.J., Cuda, F., Beyaert, M., Houghton, F.D., Cagampang, F.R., Tavassoli, A., AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization. Chem. Biol. 22 (2015), 838–848.
3. Banko, M.R., Allen, J.J., Schaffer, B.E., Wilker, E.W., Tsou, P., White, J.L., Villén, J., Wang, B., Kim, S.R., Sakamoto, K., et al. Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis. Mol. Cell 44 (2011), 878–892.
4. Calabrese, M.F., Rajamohan, F., Harris, M.S., Caspers, N.L., Magyar, R., Withka, J.M., Wang, H., Borzilleri, K.A., Sahasrabudhe, P.V., Hoth, L.R., et al. Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms. Structure 22 (2014), 1161–1172.
5. Cantó, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P., Auwerx, J., AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458 (2009), 1056–1060.
6. Cao, J., Meng, S., Chang, E., Beckwith-Fickas, K., Xiong, L., Cole, R.N., Radovick, S., Wondisford, F.E., He, L., Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). J. Biol. Chem. 289 (2014), 20435–20446.
7. Chen, L., Wang, J., Zhang, Y.-Y., Yan, S.F., Neumann, D., Schlattner, U., Wang, Z.-X., Wu, J.-W., AMP-activated protein kinase undergoes nucleotide-dependent conformational changes. Nat. Struct. Mol. Biol. 19 (2012), 716–718.
8. Chen, L., Xin, F.-J., Wang, J., Hu, J., Zhang, Y.-Y., Wan, S., Cao, L.-S., Lu, C., Li, P., Yan, S.F., et al. Conserved regulatory elements in AMPK. Nature 498 (2013), E8–E10.
9. Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R., et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3 (2006), 403–416.
10. Coughlan, K.A., Valentine, R.J., Sudit, B.S., Allen, K., Dagon, Y., Kahn, B.B., Ruderman, N.B., Saha, A.K., PKD1 Inhibits AMPKα2 through Phosphorylation of Serine 491 and Impairs Insulin Signaling in Skeletal Muscle Cells. J. Biol. Chem. 291 (2016), 5664–5675.
11. Dagon, Y., Hur, E., Zheng, B., Wellenstein, K., Cantley, L.C., Kahn, B.B., p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. Cell Metab. 16 (2012), 104–112.
12. DeRan, M., Yang, J., Shen, C.-H., Peters, E.C., Fitamant, J., Chan, P., Hsieh, M., Zhu, S., Asara, J.M., Zheng, B., et al. Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 9 (2014), 495–503.
13. Duca, F.A., Côté, C.D., Rasmussen, B.A., Zadeh-Tahmasebi, M., Rutter, G.A., Filippi, B.M., Lam, T.K.T., Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat. Med. 21 (2015), 506–511.
14. Egan, D.F., Shackelford, D.B., Mihaylova, M.M., Gelino, S., Kohnz, R.A., Mair, W., Vasquez, D.S., Joshi, A., Gwinn, D.M., Taylor, R., et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331 (2011), 456–461.
15. Faller, W.J., Jackson, T.J., Knight, J.R.P., Ridgway, R.A., Jamieson, T., Karim, S.A., Jones, C., Radulescu, S., Huels, D.J., Myant, K.B., et al. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature 517 (2015), 497–500.
16. Ford, R.J., Fullerton, M.D., Pinkosky, S.L., Day, E.A., Scott, J.W., Oakhill, J.S., Bujak, A.L., Smith, B.K., Crane, J.D., Blümer, R.M., et al. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. Biochem. J. 468 (2015), 125–132.
17. Fullerton, M.D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H.M., Ford, R.J., Palanivel, R., O'Brien, M., et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat. Med. 19 (2013), 1649–1654.
18. Fullerton, M.D., Ford, R.J., McGregor, C.P., LeBlond, N.D., Snider, S.A., Stypa, S.A., Day, E.A., Lhoták, Š., Schertzer, J.D., Austin, R.C., et al. Salicylate improves macrophage cholesterol homeostasis via activation of Ampk. J. Lipid Res. 56 (2015), 1025–1033.
19. Garcia-Haro, L., Garcia-Gimeno, M.A., Neumann, D., Beullens, M., Bollen, M., Sanz, P., The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells. FASEB J. 24 (2010), 5080–5091.
20. Gómez-Galeno, J.E., Dang, Q., Nguyen, T.H., Boyer, S.H., Grote, M.P., Sun, Z., Chen, M., Craigo, W.A., van Poelje, P.D., MacKenna, D.A., et al. A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis. ACS Med. Chem. Lett. 1 (2010), 478–482.
21. Göransson, O., McBride, A., Hawley, S.A., Ross, F.A., Shpiro, N., Foretz, M., Viollet, B., Hardie, D.G., Sakamoto, K., Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J. Biol. Chem. 282 (2007), 32549–32560.
22. Gowans, G.J., Hawley, S.A., Ross, F.A., Hardie, D.G., AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab. 18 (2013), 556–566.
23. Greer, E.L., Oskoui, P.R., Banko, M.R., Maniar, J.M., Gygi, M.P., Gygi, S.P., Brunet, A., The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282 (2007), 30107–30119.
24. Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., Turk, B.E., Shaw, R.J., AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30 (2008), 214–226.
25. Hardie, D.G., AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62 (2013), 2164–2172.
26. Hardie, D.G., AMPK–sensing energy while talking to other signaling pathways. Cell Metab. 20 (2014), 939–952.
27. Hardie, D.G., Schaffer, B.E., Brunet, A., AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs. Trends Cell Biol. 26 (2016), 190–201.
28. Hawley, S.A., Boudeau, J., Reid, J.L., Mustard, K.J., Udd, L., Mäkelä, T.P., Alessi, D.R., Hardie, D.G., Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol., 2, 2003, 28.
29. Hawley, S.A., Pan, D.A., Mustard, K.J., Ross, L., Bain, J., Edelman, A.M., Frenguelli, B.G., Hardie, D.G., Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2 (2005), 9–19.
30. Hawley, S.A., Ross, F.A., Chevtzoff, C., Green, K.A., Evans, A., Fogarty, S., Towler, M.C., Brown, L.J., Ogunbayo, O.A., Evans, A.M., Hardie, D.G., Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 11 (2010), 554–565.
31. Hawley, S.A., Fullerton, M.D., Ross, F.A., Schertzer, J.D., Chevtzoff, C., Walker, K.J., Peggie, M.W., Zibrova, D., Green, K.A., Mustard, K.J., et al. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336 (2012), 918–922.
32. Hawley, S.A., Ross, F.A., Gowans, G.J., Tibarewal, P., Leslie, N.R., Hardie, D.G., Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells. Biochem. J. 459 (2014), 275–287.
33. He, L., Wondisford, F.E., Metformin action: concentrations matter. Cell Metab. 21 (2015), 159–162.
34. He, G., Zhang, Y.-W., Lee, J.-H., Zeng, S.X., Wang, Y.V., Luo, Z., Dong, X.C., Viollet, B., Wahl, G.M., Lu, H., AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity. Mol. Cell. Biol. 34 (2014), 148–157.
35. Heathcote, H.R., Mancini, S.J., Strembitska, A., Jamal, K., Reihill, J.A., Palmer, T.M., Gould, G.W., Salt, I.P., Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487. Biochem. J. 473 (2016), 4681–4697.
36. Hoffman, N.J., Parker, B.L., Chaudhuri, R., Fisher-Wellman, K.H., Kleinert, M., Humphrey, S.J., Yang, P., Holliday, M., Trefely, S., Fazakerley, D.J., et al. Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 22 (2015), 922–935.
37. Hong, Y.H., Varanasi, U.S., Yang, W., Leff, T., AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J. Biol. Chem. 278 (2003), 27495–27501.
38. Hoppe, S., Bierhoff, H., Cado, I., Weber, A., Tiebe, M., Grummt, I., Voit, R., AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc. Natl. Acad. Sci. USA 106 (2009), 17781–17786.
39. Horman, S., Morel, N., Vertommen, D., Hussain, N., Neumann, D., Beauloye, C., El Najjar, N., Forcet, C., Viollet, B., Walsh, M.P., et al. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J. Biol. Chem. 283 (2008), 18505–18512.
40. Houde, V.P., Ritorto, M.S., Gourlay, R., Varghese, J., Davies, P., Shpiro, N., Sakamoto, K., Alessi, D.R., Investigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activity. Biochem. J. 458 (2014), 41–56.
41. Hunter, R.W., Foretz, M., Bultot, L., Fullerton, M.D., Deak, M., Ross, F.A., Hawley, S.A., Shpiro, N., Viollet, B., Barron, D., et al. Mechanism of action of compound-13: an α1-selective small molecule activator of AMPK. Chem. Biol. 21 (2014), 866–879.
42. Hurley, R.L., Anderson, K.A., Franzone, J.M., Kemp, B.E., Means, A.R., Witters, L.A., The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280 (2005), 29060–29066.
43. Hurley, R.L., Barré, L.K., Wood, S.D., Anderson, K.A., Kemp, B.E., Means, A.R., Witters, L.A., Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J. Biol. Chem. 281 (2006), 36662–36672.
44. Inoki, K., Zhu, T., Guan, K.L., TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 (2003), 577–590.
45. Jäger, S., Handschin, C., St-Pierre, J., Spiegelman, B.M., AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 104 (2007), 12017–12022.
46. Jeon, S.-M., Chandel, N.S., Hay, N., AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485 (2012), 661–665.
47. Joo, M.S., Kim, W.D., Lee, K.Y., Kim, J.H., Koo, J.H., Kim, S.G., AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550. Mol. Cell. Biol. 36 (2016), 1931–1942.
48. Jordan, S.D., Lamia, K.A., AMPK at the crossroads of circadian clocks and metabolism. Mol. Cell. Endocrinol. 366 (2013), 163–169.
49. Joseph, B.K., Liu, H.-Y., Francisco, J., Pandya, D., Donigan, M., Gallo-Ebert, C., Giordano, C., Bata, A., Nickels, J.T. Jr., Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d. J. Biol. Chem. 290 (2015), 10588–10598.
50. Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T., Uyeda, K., Mechanism for fatty acid “sparing” effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem. 277 (2002), 3829–3835.
51. Kim, J., Kundu, M., Viollet, B., Guan, K.-L., AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13 (2011), 132–141.
52. Kim, J., Kim, Y.C., Fang, C., Russell, R.C., Kim, J.H., Fan, W., Liu, R., Zhong, Q., Guan, K.-L., Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152 (2013), 290–303.
53. Kim, S.-J., Tang, T., Abbott, M., Viscarra, J.A., Wang, Y., Sul, H.S., AMPK Phosphorylates Desnutrin/ATGL and Hormone-Sensitive Lipase To Regulate Lipolysis and Fatty Acid Oxidation within Adipose Tissue. Mol. Cell. Biol. 36 (2016), 1961–1976.
54. Koo, S.-H., Flechner, L., Qi, L., Zhang, X., Screaton, R.A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437 (2005), 1109–1111.
55. Lamia, K.A., Sachdeva, U.M., DiTacchio, L., Williams, E.C., Alvarez, J.G., Egan, D.F., Vasquez, D.S., Juguilon, H., Panda, S., Shaw, R.J., et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 326 (2009), 437–440.
56. Lamia, K.A., Papp, S.J., Yu, R.T., Barish, G.D., Uhlenhaut, N.H., Jonker, J.W., Downes, M., Evans, R.M., Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 480 (2011), 552–556.
57. Lee, J.O., Lee, S.K., Kim, N., Kim, J.H., You, G.Y., Moon, J.W., Jie, S., Kim, S.J., Lee, Y.W., Kang, H.J., et al. E3 ubiquitin ligase, WWP1, interacts with AMPKα2 and down-regulates its expression in skeletal muscle C2C12 cells. J. Biol. Chem. 288 (2013), 4673–4680.
58. Leprivier, G., Remke, M., Rotblat, B., Dubuc, A., Mateo, A.-R.F., Kool, M., Agnihotri, S., El-Naggar, A., Yu, B., Somasekharan, S.P., et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153 (2013), 1064–1079.
59. Li, Y., Xu, S., Mihaylova, M.M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J.Y.J., et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13 (2011), 376–388.
60. Li, X., Wang, L., Zhou, X.E., Ke, J., de Waal, P.W., Gu, X., Tan, M.H.E., Wang, D., Wu, D., Xu, H.E., Melcher, K., Structural basis of AMPK regulation by adenine nucleotides and glycogen. Cell Res. 25 (2015), 50–66.
61. Li, Y.-H., Luo, J., Mosley, Y.-Y.C., Hedrick, V.E., Paul, L.N., Chang, J., Zhang, G., Wang, Y.-K., Banko, M.R., Brunet, A., et al. AMP-Activated Protein Kinase Directly Phosphorylates and Destabilizes Hedgehog Pathway Transcription Factor GLI1 in Medulloblastoma. Cell Rep. 12 (2015), 599–609.
62. Liang, J., Xu, Z.-X., Ding, Z., Lu, Y., Yu, Q., Werle, K.D., Zhou, G., Park, Y.-Y., Peng, G., Gambello, M.J., Mills, G.B., Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance. Nat. Commun., 6, 2015, 7926.
63. Mack, H.I.D., Zheng, B., Asara, J.M., Thomas, S.M., AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization. Autophagy 8 (2012), 1197–1214.
64. Madiraju, A.K., Erion, D.M., Rahimi, Y., Zhang, X.-M., Braddock, D.T., Albright, R.A., Prigaro, B.J., Wood, J.L., Bhanot, S., MacDonald, M.J., et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510 (2014), 542–546.
65. Mansueto, G., Armani, A., Viscomi, C., D'Orsi, L., De Cegli, R., Polishchuk, E.V., Lamperti, C., Di Meo, I., Romanello, V., Marchet, S., et al. Transcription Factor EB Controls Metabolic Flexibility during Exercise. Cell Metab. 25 (2017), 182–196.
66. McBride, A., Ghilagaber, S., Nikolaev, A., Hardie, D.G., The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab. 9 (2009), 23–34.
67. Mihaylova, M.M., Vasquez, D.S., Ravnskjaer, K., Denechaud, P.-D., Yu, R.T., Alvarez, J.G., Downes, M., Evans, R.M., Montminy, M., Shaw, R.J., Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145 (2011), 607–621.
68. Miller, R.A., Chu, Q., Xie, J., Foretz, M., Viollet, B., Birnbaum, M.J., Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494 (2013), 256–260.
69. Miyamoto, T., Rho, E., Sample, V., Akano, H., Magari, M., Ueno, T., Gorshkov, K., Chen, M., Tokumitsu, H., Zhang, J., Inoue, T., Compartmentalized AMPK signaling illuminated by genetically encoded molecular sensors and actuators. Cell Rep. 11 (2015), 657–670.
70. Mo, J.-S., Meng, Z., Kim, Y.C., Park, H.W., Hansen, C.G., Kim, S., Lim, D.-S., Guan, K.-L., Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat. Cell Biol. 17 (2015), 500–510.
71. Mouchiroud, L., Eichner, L.J., Shaw, R.J., Auwerx, J., Transcriptional coregulators: fine-tuning metabolism. Cell Metab. 20 (2014), 26–40.
72. Oakhill, J.S., Chen, Z.-P., Scott, J.W., Steel, R., Castelli, L.A., Ling, N., Macaulay, S.L., Kemp, B.E., β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc. Natl. Acad. Sci. USA 107 (2010), 19237–19241.
73. Oakhill, J.S., Steel, R., Chen, Z.P., Scott, J.W., Ling, N., Tam, S., Kemp, B.E., AMPK is a direct adenylate charge-regulated protein kinase. Science 332 (2011), 1433–1435.
74. Ouyang, J., Parakhia, R.A., Ochs, R.S., Metformin activates AMP kinase through inhibition of AMP deaminase. J. Biol. Chem. 286 (2011), 1–11.
75. Pineda, C.T., Ramanathan, S., Fon Tacer, K., Weon, J.L., Potts, M.B., Ou, Y.-H., White, M.A., Potts, P.R., Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell 160 (2015), 715–728.
76. Pirkmajer, S., Kulkarni, S.S., Tom, R.Z., Ross, F.A., Hawley, S.A., Hardie, D.G., Zierath, J.R., Chibalin, A.V., Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation. Diabetes 64 (2015), 360–369.
77. Plaideau, C., Lai, Y.-C., Kviklyte, S., Zanou, N., Löfgren, L., Andersén, H., Vertommen, D., Gailly, P., Hue, L., Bohlooly-Y, M., et al. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle. Chem. Biol. 21 (2014), 1497–1510.
78. Racanelli, A.C., Rothbart, S.B., Heyer, C.L., Moran, R.G., Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Cancer Res. 69 (2009), 5467–5474.
79. Ross, F.A., MacKintosh, C., Hardie, D.G., AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours. FEBS J. 283 (2016), 2987–3001.
80. Sanders, M.J., Ali, Z.S., Hegarty, B.D., Heath, R., Snowden, M.A., Carling, D., Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J. Biol. Chem. 282 (2007), 32539–32548.
81. Schaffer, B.E., Levin, R.S., Hertz, N.T., Maures, T.J., Schoof, M.L., Hollstein, P.E., Benayoun, B.A., Banko, M.R., Shaw, R.J., Shokat, K.M., Brunet, A., Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large-Scale Substrate Prediction. Cell Metab. 22 (2015), 907–921.
82. Scott, J.W., Ling, N., Issa, S.M.A., Dite, T.A., O'Brien, M.T., Chen, Z.-P., Galic, S., Langendorf, C.G., Steinberg, G.R., Kemp, B.E., Oakhill, J.S., Small molecule drug A-769662 and AMP synergistically activate naive AMPK independent of upstream kinase signaling. Chem. Biol. 21 (2014), 619–627.
83. Shao, D., Oka, S., Liu, T., Zhai, P., Ago, T., Sciarretta, S., Li, H., Sadoshima, J., A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation. Cell Metab. 19 (2014), 232–245.
84. Shaw, R.J., Kosmatka, M., Bardeesy, N., Hurley, R.L., Witters, L.A., DePinho, R.A., Cantley, L.C., The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 101 (2004), 3329–3335.
85. Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S.-H., Bardeesy, N., Depinho, R.A., Montminy, M., Cantley, L.C., The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 (2005), 1642–1646.
86. Shin, H.-J.R., Kim, H., Oh, S., Lee, J.-G., Kee, M., Ko, H.-J., Kweon, M.-N., Won, K.-J., Baek, S.H., AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 534 (2016), 553–557.
87. Sujobert, P., Poulain, L., Paubelle, E., Zylbersztejn, F., Grenier, A., Lambert, M., Townsend, E.C., Brusq, J.-M., Nicodeme, E., Decrooqc, J., et al. Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia. Cell Rep. 11 (2015), 1446–1457.
88. Suter, M., Riek, U., Tuerk, R., Schlattner, U., Wallimann, T., Neumann, D., Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281 (2006), 32207–32216.
89. Suzuki, T., Bridges, D., Nakada, D., Skiniotis, G., Morrison, S.J., Lin, J.D., Saltiel, A.R., Inoki, K., Inhibition of AMPK catabolic action by GSK3. Mol. Cell 50 (2013), 407–419.
90. Toyama, E.Q., Herzig, S., Courchet, J., Lewis, T.L. Jr., Losón, O.C., Hellberg, K., Young, N.P., Chen, H., Polleux, F., Chan, D.C., Shaw, R.J., Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351 (2016), 275–281.
91. Um, J.H., Yang, S., Yamazaki, S., Kang, H., Viollet, B., Foretz, M., Chung, J.H., Activation of 5′-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. J. Biol. Chem. 282 (2007), 20794–20798.
92. Vila, I.K., Yao, Y., Kim, G., Xia, W., Kim, H., Kim, S.-J., Park, M.-K., Hwang, J.P., González-Billalabeitia, E., Hung, M.-C., et al. A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy. Cancer Cell 31 (2017), 208–224.
93. Wada, S., Neinast, M., Jang, C., Ibrahim, Y.H., Lee, G., Babu, A., Li, J., Hoshino, A., Rowe, G.C., Rhee, J., et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 30 (2016), 2551–2564.
94. Wang, W., Xiao, Z.-D., Li, X., Aziz, K.E., Gan, B., Johnson, R.L., Chen, J., AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat. Cell Biol. 17 (2015), 490–499.
95. Weerasekara, V.K., Panek, D.J., Broadbent, D.G., Mortenson, J.B., Mathis, A.D., Logan, G.N., Prince, J.T., Thomson, D.M., Thompson, J.W., Andersen, J.L., Metabolic-stress-induced rearrangement of the 14-3-3ζ interactome promotes autophagy via a ULK1- and AMPK-regulated 14-3-3ζ interaction with phosphorylated Atg9. Mol. Cell. Biol. 34 (2014), 4379–4388.
96. Woods, A., Johnstone, S.R., Dickerson, K., Leiper, F.C., Fryer, L.G.D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., Carling, D., LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13 (2003), 2004–2008.
97. Woods, A., Dickerson, K., Heath, R., Hong, S.-P., Momcilovic, M., Johnstone, S.R., Carlson, M., Carling, D., Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2 (2005), 21–33.
98. Wu, N., Zheng, B., Shaywitz, A., Dagon, Y., Tower, C., Bellinger, G., Shen, C.-H., Wen, J., Asara, J., McGraw, T.E., et al. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol. Cell 49 (2013), 1167–1175.
99. Xiao, B., Sanders, M.J., Underwood, E., Heath, R., Mayer, F.V., Carmena, D., Jing, C., Walker, P.A., Eccleston, J.F., Haire, L.F., et al. Structure of mammalian AMPK and its regulation by ADP. Nature 472 (2011), 230–233.
100. Xiao, B., Sanders, M.J., Carmena, D., Bright, N.J., Haire, L.F., Underwood, E., Patel, B.R., Heath, R.B., Walker, P.A., Hallen, S., et al. Structural basis of AMPK regulation by small molecule activators. Nat. Commun., 4, 2013, 3017.
101. Xin, F.-J., Wang, J., Zhao, R.-Q., Wang, Z.-X., Wu, J.-W., Coordinated regulation of AMPK activity by multiple elements in the α-subunit. Cell Res. 23 (2013), 1237–1240.
102. Yang, Q., Liang, X., Sun, X., Zhang, L., Fu, X., Rogers, C.J., Berim, A., Zhang, S., Wang, S., Wang, B., et al. AMPK/α-Ketoglutarate Axis Dynamically Mediates DNA Demethylation in the Prdm16 Promoter and Brown Adipogenesis. Cell Metab. 24 (2016), 542–554.
103. Young, N.P., Kamireddy, A., Van Nostrand, J.L., Eichner, L.J., Shokhirev, M.N., Dayn, Y., Shaw, R.J., AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes. Genes Dev. 30 (2016), 535–552.
104. Zhang, Y.-L., Guo, H., Zhang, C.-S., Lin, S.-Y., Yin, Z., Peng, Y., Luo, H., Shi, Y., Lian, G., Zhang, C., et al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab. 18 (2013), 546–555.
105. Zhang, C.-S., Jiang, B., Li, M., Zhu, M., Peng, Y., Zhang, Y.-L., Wu, Y.-Q., Li, T.Y., Liang, Y., Lu, Z., et al. The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20 (2014), 526–540.
106. Zhou, C., Ma, K., Gao, R., Mu, C., Chen, L., Liu, Q., Luo, Q., Feng, D., Zhu, Y., Chen, Q., Regulation of mATG9 trafficking by Src- and ULK1-mediated phosphorylation in basal and starvation-induced autophagy. Cell Res. 27 (2017), 184–201.
107. Zmijewski, J.W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E.R., Abraham, E., Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J. Biol. Chem. 285 (2010), 33154–33164.